Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study

This article has no abstract
Epistemonikos ID: db5d2573f8c862f5a26a09ae11c11331d92a7b7f
First added on: Feb 16, 2025